Evolus's top three insider shareholders as of July 24, 2026 are Inc. Medytox (Other, 3.38Mn shares), Vikram Malik (Director, 1.14Mn shares), David Moatazedi (Director, 604.70K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| David N Gill | - | 86,887 | 0 | 19 Feb, 2026 |
| Peter C Farrell | - | 43,174 | 0 | 31 Jan, 2023 |
| Lauren P Silvernail | - | 141,571 | 0 | 18 May, 2022 |
| Robert Hayman | - | 54,856 | 0 | 09 Feb, 2024 |
| Albert G Iii White | - | 95,937 | 0 | 19 Feb, 2026 |
| Simone Blank | - | 0 | 482,783 | 15 Aug, 2023 |
| Rui Avelar | - | 427,423 | 0 | 20 Mar, 2026 |
| Karah Herdman Parschauer | - | 77,742 | 0 | 19 Feb, 2026 |
| David Moatazedi | - | 604,700 | 0 | 20 Mar, 2026 |
| Vikram Malik | - | 0 | 1,143,701 | 25 Aug, 2021 |
| Crystal Muilenburg | Chief Marketing Officer | 134,248 | 0 | 10 Mar, 2022 |
| Inc. Medytox | - | 3,381,326 | 0 | 18 Oct, 2023 |
| Brady Stewart | - | 134,188 | 0 | 19 Feb, 2026 |
| Sandra Beaver | Chief Financial Officer | 167,089 | 0 | 14 May, 2025 |
| Tomoko Yamagishi-Dressler | Chief Marketing Officer | 89,949 | 0 | 26 Aug, 2025 |
| Tatjana Mitchell | Chief Financial Officer | 226,092 | 0 | 19 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Mar, 2026 | David Moatazedi | Common Stock | D | 13,669 | $4.75 | 604,700 | D | S |
| 20 Mar, 2026 | Rui Avelar | Common Stock | D | 3,119 | $4.75 | 427,423 | D | S |
| 16 Mar, 2026 | David Moatazedi | Common Stock | A | 67,489 | $0.00 | 735,089 | D | M |
| 16 Mar, 2026 | Rui Avelar | Common Stock | A | 8,804 | $0.00 | 460,538 | D | M |
| 17 Mar, 2026 | David Moatazedi | Common Stock | D | 116,720 | $4.89 | 618,369 | D | S |
| 17 Mar, 2026 | Rui Avelar | Common Stock | D | 29,996 | $4.89 | 430,542 | D | S |
| 16 Mar, 2026 | David Moatazedi | Performance Restricted Stock Units | D | 67,489 | $0.00 | 67,488 | D | M |
| 16 Mar, 2026 | Rui Avelar | Performance Restricted Stock Units | D | 8,804 | $0.00 | 8,802 | D | M |
| 17 Feb, 2026 | Albert G Iii White | Common Stock | A | 45,559 | $0.00 | 95,937 | D | A |
| 17 Feb, 2026 | Brady Stewart | Common Stock | A | 45,559 | $0.00 | 134,188 | D | A |
| 17 Feb, 2026 | David Moatazedi | Common Stock | A | 313,212 | $0.00 | 667,600 | D | A |
| 17 Feb, 2026 | Vikram Malik | Common Stock | A | 45,559 | $0.00 | 321,109 | D | A |
| 17 Feb, 2026 | Vikram Malik | Common Stock | A | 45,559 | $0.00 | 321,109 | D | A |
| 17 Feb, 2026 | Tatjana Mitchell | Common Stock | A | 121,489 | $0.00 | 226,092 | D | A |
| 17 Feb, 2026 | Albert G Iii White | Common Stock | A | 45,559 | $0.00 | 95,937 | D | A |
| 17 Feb, 2026 | Albert G Iii White | Common Stock | A | 45,559 | $0.00 | 95,937 | D | A |
| 17 Feb, 2026 | Tatjana Mitchell | Common Stock | A | 121,489 | $0.00 | 226,092 | D | A |
| 17 Feb, 2026 | Brady Stewart | Common Stock | A | 45,559 | $0.00 | 134,188 | D | A |
| 17 Feb, 2026 | Rui Avelar | Common Stock | A | 94,913 | $0.00 | 451,734 | D | A |
| 17 Feb, 2026 | Vikram Malik | Common Stock | A | 45,559 | $0.00 | 321,109 | D | A |